Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Peter L. Summers"'
Autor:
Alan L. Schmaljohn, Stephen A. Harrison, Connie S. Schmaljohn, David J. McClain, Peter L. Summers
Publikováno v:
Journal of Medical Virology. 60:77-85
We evaluated a vaccinia-vectored vaccine for hemorrhagic fever with renal syndrome in clinical trials. A Phase I dose-escalation study in 16 volunteers divided into four groups demonstrated that subcutaneous inoculation of approximately 10(7) plaque-
Autor:
Shannon M. Harrison, David J. McClain, James D. Arthur, Jess A. Graham, John Cruz, Francis A. Ennis, Curtis L. Yeager, Michael S. Wright, Paul H. Gibbs, Peter L. Summers
Publikováno v:
The Journal of Infectious Diseases. 175:756-763
To develop a less reactogenic but equally immunogenic vaccine, this study of 91 human volunteers compared the safety and immunogenic potency of a new, cell culture-derived vaccinia virus vaccine administered intradermally and intramuscularly with the
Autor:
Kenneth H. Eckels, Peter L. Summers, Doria R. Dubois, Charles H. Hoke, Carol O. Tacket, Robert R. Edelman, Steven S. Wasserman, David W. Vaughn
Publikováno v:
Journal of Infectious Diseases. 170:1448-1455
A dengue-1 candidate vaccine (45AZ5), previously found to be underattenuated in 2 volunteers, was further attenuated by passage in primary dog kidney (PDK) cell cultures. New candidate vaccines prepared from three levels of PDK-passaged virus, PDK-10
Publikováno v:
The American journal of tropical medicine and hygiene. 56(5)
Due to the lack of an animal model, previous studies of sandfly fever have relied upon human challenge trials. We examined the infectivity and potential pathogenicity of sandfly fever virus in cynomolgus monkeys (Macaca fascicularis). Three different
Publikováno v:
Yonsei Medical Journal. 42:278
The efficacy of a formalin-inactivated hemorrhagic fever with renal syndrome (HFRS) vaccine and the effectiveness of a related vaccination program have not been previously evaluated. We measured the primary immune responses to Hantavax by plaque redu
Autor:
Peter L. Summers, Robert Scott, K. D. T. Jesrani, Thomas E. Simms, William H. Bancroft, Philip K. Russell, Doria R. Dubois, Kenneth H. Eckels, Charles H. Hoke, D. Tsoulos
Publikováno v:
Journal of Infectious Diseases. 149:1005-1010
A live dengue virus type 2 (dengue-2) vaccine (PR-159/S-1) was tested for reactogenicity and immunogenicity in a placebo-controlled, double-blind clinical trial involving 98 soldiers. Seroconversion rates based on the development of neutralizing anti
Autor:
McClain, David J., Summers, Peter L., Harrison, Stephen A., Schmaljohn, Alan L., Schmaljohn, Connie S.
Publikováno v:
Journal of Medical Virology; 2000, Vol. 60 Issue 1, p77-85, 9p
Autor:
Edelman, Robert, Tacket, Carol O., Wasserman, Steven S., Vaughn, David W., Eckels, Kenneth H., Dubois, Doria R., Summers, Peter L., Hoke, Charles H.
Publikováno v:
Journal of Infectious Diseases; 1994, Vol. 170 Issue 6, p1448-1455, 8p
Autor:
Innis, Bruce L., Eckels, Kenneth H., Kraiselburd, Edmundo, Dubois, Doria R., Meadors, Gilcin F., Gubler, Duane J., Burke, Donald S., Bancroft, William H.
Publikováno v:
Journal of Infectious Diseases; 1988, Vol. 158 Issue 4, p876-880, 5p
Autor:
McClain, David J., Harrison, Shannon, Yeager, Curtis L., Cruz, John, Ennis, Francis A., Gibbs, Paul, Wright, Michael S., Summers, Peter L., Arthur, James D., Graham, Jess A.
Publikováno v:
Journal of Infectious Diseases; 1997, Vol. 175 Issue 4, p756-763, 8p